LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

End of the Road for Adjunctive Vitamin D Therapy for Pulmonary Tuberculosis?

Photo from wikipedia

Adjunctive and host directed therapies are increasingly recognised as an important target in the quest for novel effective antituberculous therapy.(1) The global increase in drug resistance to antibiotics suggests that… Click to show full abstract

Adjunctive and host directed therapies are increasingly recognised as an important target in the quest for novel effective antituberculous therapy.(1) The global increase in drug resistance to antibiotics suggests that effective adjunctive medications may provide an alternative avenue to treat infections. Vitamin D supplementation has been hypothesized as a potential adjunctive agent for the treatment of tuberculosis and evaluated in several trials.(2) Ganmaa and colleagues (2) evaluated the effectiveness of adjunctive vitamin D on sputum culture conversion and assessed the influence of key vitamin D pathway single nucleotide polymorphisms (SNPs) on sputum culture conversion concluding that there is no evidence that vitamin D supplementation improved outcomes.

Keywords: end road; adjunctive vitamin; tuberculosis; therapy; vitamin; road adjunctive

Journal Title: American journal of respiratory and critical care medicine
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.